Home » Stocks » EVFM

Evofem Biosciences, Inc. (EVFM)

Stock Price: $3.60 USD -0.35 (-8.86%)
Updated Mar 3, 2021 4:00 PM EST - Market closed
After-hours: $3.65 +0.05 (1.39%) Mar 3, 7:54 PM
Market Cap 292.61M
Revenue (ttm) 278,000
Net Income (ttm) -114.43M
Shares Out 81.21M
EPS (ttm) -1.93
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day March 3
Last Price $3.60
Previous Close $3.95
Change ($) -0.35
Change (%) -8.86%
Day's Open 3.95
Day's Range 3.52 - 3.95
Day's Volume 2,690,242
52-Week Range 1.91 - 6.87

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
InvestorPlace - 1 week ago

These penny stocks are companies that have a crucial year ahead in terms of industry turnaround or company specific product development. The post 7 Penny Stocks In a Make-or-Break Year appeare...

Other stocks mentioned: BORR, IBIO, KSHB, OILFF, SB, TMBR
PRNewsWire - 1 week ago

SAN DIEGO, Feb. 18, 2021 /PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ: EVFM) will hold a webcast and conference call to discuss the Company's financial results and business highlights for ...

Seeking Alpha - 2 months ago

Initial prescription data for Phexxi looks very positive. Both the number of new users and estimated revenues to date have exceeded my initial modeling.

PRNewsWire - 2 months ago

SAN DIEGO, Dec. 22, 2020 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced it has entered into an agreement with the U.S. Centers for Medicare and Medicaid Services (CMS...

PRNewsWire - 3 months ago

SAN DIEGO, Dec. 3, 2020 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced that the U.S. Department of Veterans Affairs (VA) has awarded the Company a contract for the pu...

PRNewsWire - 3 months ago

SAN DIEGO, Nov. 20, 2020 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced it will participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference, taking pla...

Seeking Alpha - 3 months ago

EVFM has dipped back into the low $2s due to the daunting task of launching a product without a major company's assistance. I review recent developments and then run my estimates of revenue ra...

Seeking Alpha - 3 months ago

Evofem Biosciences, Inc. (EVFM) CEO Saundra Pelletier on Q3 2020 Results - Earnings Call Transcript

Seeking Alpha - 3 months ago

Evofem Biosciences, Inc. (EVFM) CEO Saundra Pelletier on Q3 2020 Results - Quick Version Earnings Call Transcript

PRNewsWire - 3 months ago

SAN DIEGO, Nov. 9, 2020 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) ("Evofem" or the "Company"), today reported financial results for the three- and nine- month periods ended Sept...

Seeking Alpha - 4 months ago

Evofem vaginal pH modulation technology is a differentiated product being used to target unmet needs in women's health.

PRNewsWire - 4 months ago

SAN DIEGO, Oct. 20, 2020 /PRNewswire/ -- Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced enrollment of the first patient in its pivotal Phase 3 clinical trial evaluating the safety an...

PRNewsWire - 5 months ago

SAN DIEGO, Sept. 16, 2020 /PRNewswire/ -- Evofem Biosciences, Inc.

Zacks Investment Research - 5 months ago

Investors need to pay close attention to Evofem Biosciences (EVFM) stock based on the movements in the options market lately.

Seeking Alpha - 5 months ago

Evofem: Why I Bought Friday's Massive Spike Down

The Motley Fool - 5 months ago

The company's CEO made a noteworthy move.

PRNewsWire - 6 months ago

SAN DIEGO, Aug. 21, 2020 /PRNewswire/ -- Evofem Biosciences, Inc.

Zacks Investment Research - 6 months ago

Investors need to pay close attention to Evofem Biosciences (EVFM) stock based on the movements in the options market lately.

Seeking Alpha - 6 months ago

Evofem Biosciences, Inc. (EVFM) CEO Saundra Pelletier on Q2 2020 Results - Earnings Call Transcript

PRNewsWire - 6 months ago

SAN DIEGO, Aug. 4, 2020 /PRNewswire/ -- Evofem Biosciences, Inc.

PRNewsWire - 8 months ago

SAN DIEGO, July 1, 2020 /PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ: EVFM), a commercial-stage biopharmaceutical company, today announced that it has issued a letter to its stockholders p...

Zacks Investment Research - 8 months ago

Investors need to pay close attention to Evofem Biosciences (EVFM) stock based on the movements in the options market lately.

Zacks Investment Research - 8 months ago

Evofem Biosciences (EVFM) saw a big move last session, as its shares jumped more than 10% on the day, amid huge volumes.

Benzinga - 8 months ago

Evofem Biosciences Inc (NASDAQ: EVFM) shares are trading higher on Monday after Piper Sandler initiated coverage on the company's stock with an Outperform rating and announced an $11 price tar...

The Motley Fool - 9 months ago

The company announced the pricing of a public offering of common stock.

PRNewsWire - 9 months ago

SAN DIEGO, June 2, 2020 /PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ: EVFM), a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to...

PRNewsWire - 9 months ago

SAN DIEGO, June 2, 2020 /PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ: EVFM), a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to...

The Motley Fool - 9 months ago

Here's why a company making a novel contraceptive will be well awarded for tackling an old problem with a new twist.

Benzinga - 9 months ago

Evofem Biosciences Inc (NASDAQ: EVFM) shares gap-opened higher Tuesday morning after a binary event panned out in the company's favor.

The Motley Fool - 9 months ago

Evofem Biosciences scored a major regulatory win last Friday.

Seeking Alpha - 9 months ago

Evofem Biosciences: FDA Approval Beginning Of Strong 2020

Market Watch - 9 months ago

Evofem Biosciences Inc. EVFM, +3.31% stock rallied in the extended session Friday after the biotech company said the Food and Drug Administration approved its birth-control gel.

PRNewsWire - 9 months ago

SAN DIEGO, May 22, 2020 /PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ: EVFM) today announced that the U.S. Food and Drug Administration (FDA) has approved Phexxi™ (lactic acid, citric acid ...

PRNewsWire - 9 months ago

INCLINE VILLAGE, Nev., May 21, 2020 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) announces that it has completed its previously announced distribution of all of ...

PRNewsWire - 9 months ago

INCLINE VILLAGE, Nev., May 18, 2020 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) announces the final distribution ratio for the previously announced distribution...

Seeking Alpha - 9 months ago

Evofem Biosciences Inc. (EVFM) CEO Saundra Pelletier on Q1 2020 Results - Earnings Call Transcript

Seeking Alpha - 11 months ago

This Small Biotech Is About To Take Off

Seeking Alpha - 11 months ago

Evofem Biosciences, Inc. (EVFM) CEO Saundra Pelletier on Q4 2019 Results - Earnings Call Transcript

InvestorPlace - 1 year ago

No matter which strategy is employed or what types of stocks are sought after, investors want to see returns. The post 7 ‘Strong Buy’ Stocks With Over 50% Upside Potential appeared first on ...

Other stocks mentioned: BYSI, EQT, ESTE, MSON, PLYA, SQNS
The Motley Fool - 1 year ago

Shares jump after the company reports upbeat clinical results. Here are the must-know details.

Market Watch - 1 year ago

Evofem Biosciences Inc. EVFM, +0.33% reported positive results in a mid-stage trial of a treatment for chlamydia and gonorrhea in women, sending its stock up 18% in premarket trade Monday.

Seeking Alpha - 1 year ago

Evofem Biosciences, Inc. (EVFM) CEO Saundra Pelletier on Q3 2019 Results - Earnings Call Transcript

Seeking Alpha - 1 year ago

The company claims a serious niche in the market of contraceptives.

GuruFocus - 1 year ago

The GuruFocus All-in-One Screener can be used to find insider trades from the past week.

Other stocks mentioned: BDSI, DSS, LGCY, MGM, RVLV
InvestorPlace - 1 year ago

These seven cheap stocks under $10 all have massive upside potential according to Wall Street's top analysts. The post 7 High-Quality Cheap Stocks to Buy With $10 appeared first on InvestorPl...

Other stocks mentioned: ACB, ADMA, CLF, INSG, OGI, ZNGA
Seeking Alpha - 1 year ago

Evofem Biosciences, Inc. (EVFM) CEO Saundra Pelletier on Q1 2019 Results - Earnings Call Transcript

Seeking Alpha - 1 year ago

Evofem's lead drug (Amphora) passed Phase 3 clinical trials. Amphora is a differentiated contraception drug. PDL will make an investment in Evofem up to 29% of equity.

Other stocks mentioned: PDLI

About EVFM

Evofem Biosciences, a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, a vaginal pH regulator for the prevention of urogenital transmission of Chlamydia trachomatis infection and Neisseria gonorrhoeae infection in women. It has a collaboration agreement with National Community Oncology Dispensing Association, Inc. to ed... [Read more...]

Industry
Biotechnology
CEO
Saundra Pelletier
Employees
53
Stock Exchange
NASDAQ
Ticker Symbol
EVFM
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to 4 analysts, the average rating for EVFM stock is "Buy." The 12-month stock price forecast is 8.40, which is an increase of 133.33% from the latest price.

Price Target
$8.40
(133.33% upside)
Analyst Consensus: Buy